Cargando…
Plasma Purification Treatment Relieves the Damage of Hyperlipidemia to PBMCs
Background: Hyperlipidemia {hypercholesterolemia [cholesterol >5.18 mmol/L) or hypertriglyceridemia [triglycerides >2.3 mmol/L], mixed hyperlipidemia [cholesterol >5.18 mmol/L and triglycerides >2.3 mmol/L], and high low-density lipoproteinemia [low-density lipoprotein (LDL) >3.4 mmol...
Autores principales: | Zhang, Xiao Meng, Gu, Yan Hong, Deng, Hao, Xu, Zheng Quan, Zhong, Ze Yuan, Lyu, Xia Jie, Jin, Hui Min, Yang, Xiu Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292646/ https://www.ncbi.nlm.nih.gov/pubmed/34307504 http://dx.doi.org/10.3389/fcvm.2021.691336 |
Ejemplares similares
-
Injury to the tunica media initiates atherogenesis in the presence of hyperlipidemia
por: Belhoul-Fakir, Hanane, et al.
Publicado: (2023) -
Novel Nongenetic Murine Model of Hyperglycemia and Hyperlipidemia-Associated Aggravated Atherosclerosis
por: Gaul, Susanne, et al.
Publicado: (2022) -
Association of ACE2 Polymorphisms and Derived Haplotypes With Obesity and Hyperlipidemia in Female Spanish Adolescents
por: Lumpuy-Castillo, Jairo, et al.
Publicado: (2022) -
Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants
por: Chen, Hongjie, et al.
Publicado: (2022) -
Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants
por: Chen, Hongjie, et al.
Publicado: (2022)